04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
Goldman Sachs is reportedly in negotiations with federal prosecutors to resolve claims about its rol...
Read More >
Many clients have asked about the state of federal antitrust enforcement during the current pandemic...
Read More >
In recent years, a number of federal appellant courts, including the Fourth Circuit, have issued opi...
Read More >
Sponsorship Brochure for That 401(k) Conference at Busch Stadium in St. Louis, MO on May 8, 2020...B...
Read More >
On February 6, 2020, Governor Andrew Cuomo signed an amendment to New York Labor Law § 592 that redu...
Read More >
On August 12, 2019, Judge Haywood S. Gilliam, Jr. of the United States District Court for the Northe...
Read More >